PYX Resources: Achieving volume and diversification milestones. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Hi - Yes I am stake building here too, very diverse and low riskmway to invest in the bio sector and as you say circa 30% discount already but I see big growth from a few of the other companies too in the coming months. Thanks.
You are ,in my reading of the situation, correct. We will get NAV either in Cash or Units. So if the NAV continues to perform, could be a nice little earner-looks like a good 30% return already, which I would settle for in a year. I am waiting for full documentation to arrive. Always a potential for NAV to fall of course , but PLE and SUMM seem to be going the right way. Have a holding and looking and increasing substantially once I have read documents.
Today, as a bit skint, but got them for 13p, showing as a sell. I don't think the increase in SUMM and PLE has been accounted for here. I'm heavily into both, so just think of the PEBI holding as a top up.
Hi - I am right in thinking that in 1 years time we get the option to take cash at NAV value OR join the Magna fund with NAV value of these shares? If I don't sell these shares will they be exchanged for the same value of magna fund shares? Thanks in advance
Think about 20p at moment. Will have to check figures. Unitisation is good news, will get shareholders NAV. I will then sell as I like buying fund assets at a discount, but looks like a good return over next 12 months. Can only see upside in the portfolio as well. Was fortunate enough to buy at 8p 5 months ago, so pretty happy. Will then move onto the next one-plenty out there trading below asset value-shares and companies.Finding them is the hard part, but research will throw them up- have a few in my portfolio.
I think 19% of portfolio - prospects at Ple look superb (I am long term holder of both Ple & Pebi) Pebi holds other very interesting bio stocks such as Summit and Arrowhead in the US. I also hold Synergy Pharma which to date has not performed well hopefully that will change. Suggest you read Cracking The Code by JM and you will be able to see the research that has gone in behind Jim's stock picks. I believe that Pebi wil be 30p + within 6 months and I have said this before when it was sub 10p. Best of luck to you if you do invest
Glad to be part of them via here, what do people think the chance of long term sustained rises are? This wads balanced portfolio but with the big PLE rise it must now be circa 30%+of our portfolio!
PLE is testing 18p again, looks like the value of PEBI's holding will be worth a good deal more than it was last quarter. 18-20p NAV perhaps?
Agree 100% - sole purpose is to create shareholder value. It will attract institutions and normally those in first derive greatest initial benefit. It will get done anyway due to the shareholdings.
I think the Magna fund with Mr Mellon as advisor will be great for PEBI and the chance to get cash NAV value in 1 year is great - it's a yes for me. Hope other holders have used there vote for the 11th Nov.
Hi, no the 12.39 buy wasn't mine, I had a quick look through ADVFN this morning and it was showing 12.5 so I didn't bother and I still don't like the spread. It was only for a top up whilst its this low, still hold just over 30,000 shares, hopefully wont get another chance to top up would be nice to see this much nearer to its NAV. Cheers PP
PP - Was that your 12.39 buy earlier? Looks to be moving on low volume but then they are mostly buys. Incredible rise yesterday, some profit taking today but still holding 17-18p. Vegas - Yes it may be the uncertainty surrounding those developments. I would think whatever the outcome, PEBI will still be undervalued come the next update. Hopefully some clarification regarding the future of this company will be provided soon
Clearly quite a few people having been selling recently maybe due to the potential change regarding the Magna fund and time till next NAV update but I continue to hold long term.
Hi shareminator, I tried as low as 775 shares and it still quoted 12.39, it must have been down to the late surge with PLE, obviously the MM's didn't want to miss the opportunity of upping the price. Good luck with your holding. Cheers PP
Pingping - that last trade for 6,583 at 12p was mine lol but I agree it could be tough to buy in large quantities. There may be some lulls in the coming month or two but should PLE and the other investments continue to perform well I can't see how this won't climb higher as we approach the next NAV update. Congrats with your PLE btw, excellent return so far!
the_sherminator think you will be very lucky now to buy at 12, tried earlier through TD and even though the ask was still 12 wouldn't let me buy any amount for less than 12.4. In hindsight that might still be a very good price but the spread a little large for me. Will try again in the morning in case there is a slight pullback on PLE even though I hope not as I am invested there to.
PLE up about 50% in the last two days I make it now, well done to those holding there. I'm not too keen buying there after such a rise but happy to pay 12p here in anticipation of an improved value update in Q114. Thanks for highlighting Arrowhead's news also an interesting development that as you say many will have missed, me included :)
Thanks for good wishes booboodog and the same goes to you. I have been buying these all way from 6p after presentation from JM - Ple now up 32% over last 2 days - that stock alone could double the SP here. Cracking the Code which I have read and re-read is a great research tool and lists many interesting potential bio- pharma investments - some good and some not so good. I think now trading at too large a discount to NAV and JM will wish to resolve this and create value.
Yes pomander I agree, I've been watching this one for a while waiting for a pull back, they've got a very decent looking portfolio with plenty of upside. As a result I've just dipped a toe in! good luck
Good time to add - Ple (largest investment) back up 20% last two days and good chance will go much higher. Probably missed by most is Arrowhead a US BioPharma held by PEBI which announced significant clinical news yesterday having recently also put in place $ 60 m of funding. I think could easily come under the radar of BP soon.
Me too, I have a few 'dogs' which are going soon for here.
No buying advice given, but will definitely be holding PEBI, and if my 2 worst investment choices, MDC, and possibly CRV show any progress, will sell and try and buy more PEBI, price depending. May even sell rest of CRV, take a large loss, but may make up for the loss in here or possibly VIP. Not a ramp.
I am beginning to grasp why PEBI has done this. It will eliminate the discount, and will allow as far as I can see the Magna fund to issue new Units. I assume this is the purpose so that PEBI/MAGNA can attract additional funds. It is very hard for an investment fund to have a rights issue when share price is trading at a discount to NAV. Normally Investment Trust's can only have a rights issue when Shares at a premium to NAV, though recently they have issued Conversion shares-warrants effectively. So that I believe is the reason for the move to be able to attract more funds without dilution of NAV. So assuming the fund continues to perform at my expected growth , looks like we have a potential 50% plus return over the next 14 months until shareholders can opt for cash or units. Looks a no brainer for me and having halved my holding when I sold -my rule to halve when 100% up, I will be now be increasing to double my usual investment holding- got another amount due into SIPP shortly. Would sell another holding, but nothing I want to get sell at the moment as all look OK for the future and the one I am disappointed with must recover surely-worst investment choice I made and broke all my investment rules-MONY. I might dump it as I still cannot believe I ignored my initial cynicism about the business model and bought in. Would cheer me up not to see that red every day when check portfolio !
Ah gotcha! ;)